IL6R and cancer: The soluble (s)IL-6R-dependent trans-signaling mediated by ADAM17 was verified as one of the reasons for the development of many cancers including lung cancer, ovarian cancer, pancreatic cancer, colorectal cancer and hepatocellular cancer [60, 61].